Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Arvinas Inc
About ARVN
Arvinas, Inc. is a clinical-stage biotechnology company. The Company, through its PROteolysis Targeting Chimera (PROTAC) protein degrader platform, is pioneering the development of protein degradation therapies designed to harness the body's natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. It is progressing multiple investigational drugs through clinical development programs, including vepdegestrant, ARV-393, ARV-102, ARV-80, and ARV-027. Vepdegestrant is an investigational orally bioavailable PROTAC protein degrader designed to target and degrade the ER for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer. It is co-developing vepdegestrant with Pfizer. ARV-393 is an investigational, orally bioavailable PROTAC to degrade BCL6, a transcriptional repressor and a regulator of normal B-cell maturation and differentiation processes. ARV-102 is in development to treat neurodegenerative diseases.
Find out what a historical investment in Arvinas Inc would be worth today using our ARVN stock calculator.
Market Capitalisation
$551.66M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
839.85K
High today
$9.12
Low today
$8.45
Open price
$8.57
52-week high
$14.51
52-week low
$6.06
Ready to start your investing journey with Stake?
Open an accountHow do I buy ARVN shares in Australia?
Buying ARVN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Arvinas Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ARVN
What is the ticker symbol of Arvinas Inc?
The ticker symbol for Arvinas Inc is ARVN.
How much is one share of ARVN?
One share of ARVN is valued at $9.11 as of 21 May 2026.
What is the market capitalisation of Arvinas Inc ARVN?
As of 21 May 2026 Arvinas Inc has a market cap of $551.66M.
What is the 52-week high for Arvinas Inc stock?
The Arvinas Inc 52-week high stock price is $14.51.
What is the 52-week low for Arvinas Inc stock?
The Arvinas Inc 52-week low stock price is $6.06.
Can I buy ARVN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ARVN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ARVN on Stake
- Buy ARVN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ARVN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ARVN related stocks